Literature DB >> 17262171

Analysis of candidate imprinted genes in PWS subjects with atypical genetics: a possible inactivating mutation in the SNURF/SNRPN minimal promoter.

Esther N Maina1, Tessa Webb1, Sarita Soni2, Joyce Whittington2, Harm Boer3, David Clarke4, Anthony Holland5.   

Abstract

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder associated with abnormalities of chromosome 15q11q13. The majority of cases result either from a deletion approximately 4 Mb in size, affecting chromosome 15 of paternal origin or from UPD(15)mat; these account for approximately 70 and approximately 20-25% of PWS cases, respectively. In the remaining 3-5% of PWS cases where neither the deletion nor UPD is detectable, PWS is thought to be caused either by a defect in the imprinting centre resulting in a failure to reset the paternally inherited chromosome 15 derived from the paternal grandmother or, very occasionally, from a balanced translocation involving a breakpoint in 15q11q13. Nine probands with a firm clinical diagnosis of PWS but who had neither a typical deletion in the PWS region nor UPD(15)mat were investigated for inactivating mutations in 11 genes located in the PWS region, including SNURF and SNRPN, which are associated with the imprinting centre. Other genes studied for mutations included MKRN3, NDN, IPW, HBII-85, HBII-13, HBII-436, HBII-438a, PAR1 and PAR5. A possibly inactivating mutation in the SNRPN minimal promoter region was identified. No other inactivating mutations were found in the remainder of our panel of PWS subjects with atypical genetics. Expression levels of several of the candidate genes for PWS were also investigated in this series of probands. The results indicate that PWS may result from a stochastic partial inactivation of important genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262171     DOI: 10.1007/s10038-007-0109-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  48 in total

1.  A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region.

Authors:  M T Jong; T A Gray; Y Ji; C C Glenn; S Saitoh; D J Driscoll; R D Nicholls
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

2.  Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region.

Authors:  J E Whittington; A J Holland; T Webb; J Butler; D Clarke; H Boer
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

3.  An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript.

Authors:  C Rougeulle; C Cardoso; M Fontés; L Colleaux; M Lalande
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

4.  Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain.

Authors:  Mei-Yi Wu; Ting-Fen Tsai; Arthur L Beaudet
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

5.  Diagnostic test for the Prader-Willi syndrome by SNRPN expression in blood.

Authors:  R Wevrick; U Francke
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

6.  The mouse Snrpn minimal promoter and its human orthologue: activity and imprinting.

Authors:  A Y Hershko; Y Finberg; B Kantor; R Shemer; A Razin
Journal:  Genes Cells       Date:  2001-11       Impact factor: 1.891

7.  The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain.

Authors:  C Rougeulle; H Glatt; M Lalande
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

8.  The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region.

Authors:  P Jay; C Rougeulle; A Massacrier; A Moncla; M G Mattei; P Malzac; N Roëckel; S Taviaux; J L Lefranc; P Cau; P Berta; M Lalande; F Muscatelli
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

9.  Imprinting-mutation mechanisms in Prader-Willi syndrome.

Authors:  T Ohta; T A Gray; P K Rogan; K Buiting; J M Gabriel; S Saitoh; B Muralidhar; B Bilienska; M Krajewska-Walasek; D J Driscoll; B Horsthemke; M G Butler; R D Nicholls
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn.

Authors:  Miguel Landers; Daria L Bancescu; Elodie Le Meur; Claire Rougeulle; Heather Glatt-Deeley; Camilynn Brannan; Françoise Muscatelli; Marc Lalande
Journal:  Nucleic Acids Res       Date:  2004-06-29       Impact factor: 16.971

View more
  5 in total

1.  Different distribution of the genetic subtypes of the Prader-Willi syndrome in the elderly.

Authors:  Margje Sinnema; Kees E P van Roozendaal; Marian A Maaskant; Hubert J M Smeets; John J M Engelen; Nieke Jonker-Houben; Constance T R M Schrander-Stumpel; Leopold M G Curfs
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

Review 2.  Genetics of pubertal timing.

Authors:  Alessandra Mancini; John C Magnotto; Ana Paula Abreu
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2022-02-05       Impact factor: 4.690

Review 3.  Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 4.  Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome.

Authors:  Chong Kun Cheon
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-09-30

5.  Behavioral profile of adults with Prader-Willi syndrome: correlations with individual and environmental variables.

Authors:  Joseba Jauregi; Virginie Laurier; Pierre Copet; Maithé Tauber; Denise Thuilleaux
Journal:  J Neurodev Disord       Date:  2013-08-06       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.